Internationally recognized neuroinflammation expert to provide strategic medical and clinical guidance for R&D programs focused on the innate immune system BOSTON and BONN, Germany, Dec. 20, 2017 /PRNewswire/ -- IFM Therapeutics, LLC (IFM), a privately held biopharmaceutical...
from PR Newswire: //www.prnewswire.co.uk/news-releases/ifm-therapeutics-llc-appoints-dr-michael-heneka-to-clinical-advisory-board-665440003.html
No comments:
Post a Comment